Walleye Trading LLC Sorrento Therapeutics, Inc. Call Options Transaction History

Walleye Trading LLC

  • $46.7 Billion
  • Q3 2024

Call Options

5 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2022

Aug 08, 2022
SELL
$1.24 - $2.33 $30,132 - $56,619
-24,300 Closed
0 $0
Q1 2022

May 16, 2022
SELL
$2.0 - $4.9 $85,800 - $210,210
-42,900 Reduced 63.84%
24,300 $57,000
Q4 2021

Feb 14, 2022
BUY
$4.65 - $7.23 $81,840 - $127,248
17,600 Added 35.48%
67,200 $312,000
Q3 2021

Nov 15, 2021
BUY
$7.41 - $10.99 $234,897 - $348,383
31,700 Added 177.09%
49,600 $378,000
Q2 2021

Aug 16, 2021
BUY
$6.35 - $10.0 $113,665 - $179,000
17,900 New
17,900 $173,000

Others Institutions Holding SRNE

# of Institutions
12
Shares Held
5.47M
Call Options Held
0
Put Options Held
0
View Full List

About Sorrento Therapeutics, Inc.

SRNE Quotes by TradingView
  • Ticker SRNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 449,952,000
  • Market Cap $148M
  • Description
  • Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...
More about SRNE
Track This Portfolio

Track Walleye Trading LLC Portfolio

Follow Walleye Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email